Open access · CC-BY
via OpenAlex
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease
Anna Masato, Nicoletta Plotegher, Francesca Terrin, Michele Sandre, Gaia Faustini, Andrea Thor, Stephen Adams, Giulia Berti, Susanna Cogo, Federica De Lazzari, Camilla Maria Fontana, Paul Anthony Martinez, Randy Strong, Rina Bandopadhyay, Marco Bisaglia
npj Parkinson s Disease · 2023 · ▲ 38 citations
Abstract
Dopamine dyshomeostasis has been acknowledged among the determinants of nigrostriatal neuron degeneration in Parkinson's disease (PD). Several studies in experimental models and postmortem PD patients underlined increasing levels of the dopamine metabolite 3,4-dihydroxyphenylacetaldehyde (DOPAL), which is highly reactive towards proteins. DOPAL has been shown to covalently modify the presynaptic protein αSynuclein (αSyn), whose misfolding and aggregation represent a major trait of PD pathology, triggering αSyn oligomerization in dopaminergic neurons. Here, we demonstrated that DOPAL elicits αSyn accumulation and hampers αSyn clearance in primary neurons. DOPAL-induced αSyn buildup lessens neuronal resilience, compromises synaptic integrity, and overwhelms protein quality control pathways in neurites. The progressive decline of neuronal homeostasis further leads to dopaminergic neuron loss and motor impairment, as showed in in vivo models. Finally, we developed a specific antibody which detected increased DOPAL-modified αSyn in human striatal tissues from idiopathic PD patients, corroborating the translational relevance of αSyn-DOPAL interplay in PD neurodegeneration.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41531-023-00485-1
- Canonical
- link ↗
- Fetched
- 2026-06-12 MST
Cite this
APA
Masato, A., Plotegher, N., Terrin, F., Sandre, M., Faustini, G., Thor, A., Adams, S., Berti, G., Cogo, S., Lazzari, F.D., Fontana, C.M., Martinez, P.A., Strong, R., Bandopadhyay, R., Bisaglia, M., Bellucci, A., Greggio, E., Valle, L.D., Boassa, D., & Bubacco, L. (2023). DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease. <em>npj Parkinson s Disease</em>. https://doi.org/10.1038/s41531-023-00485-1
Vancouver
Masato A, Plotegher N, Terrin F, Sandre M, Faustini G, Thor A, et al. DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease. npj Parkinson s Disease. 2023. doi:10.1038/s41531-023-00485-1.
BibTeX
@article{anna2023DOPALi,
title = {DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease},
author = {Anna Masato and Nicoletta Plotegher and Francesca Terrin and Michele Sandre and Gaia Faustini and Andrea Thor and Stephen Adams and Giulia Berti and Susanna Cogo and Federica De Lazzari and Camilla Maria Fontana and Paul Anthony Martinez and Randy Strong and Rina Bandopadhyay and Marco Bisaglia and Arianna Bellucci and Elisa Greggio and Luisa Dalla Valle and Daniela Boassa and Luigi Bubacco},
journal = {npj Parkinson s Disease},
year = {2023},
doi = {10.1038/s41531-023-00485-1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2024
Open access · CC-BY
Alpha Synuclein Toxicity and Non-Motor Parkinson’s
Frontiers in Cellular Neuroscience 2020
Open access · CC-BY
Amyotrophic Lateral Sclerosis: Proteins, Proteostasis, Prions, and Promises
Experimental Neurobiology 2015
Open access · OA
Mitochondrial Dysfunction in Parkinson’s Disease
Patrick Lao 2017
Open access · US-GOV
Imaging Tau in Alzheimer's Disease and Normal Aging With 18F-MK-6240
Journal of Neurochemistry 2025
Open access · CC-BY
Clearance Pathways for α‐Synuclein in Parkinson's Disease
Behavioral Neuroscience 2014
Preprint · OA